Premium
The pharmaco‐economics of peri‐operative statin therapy
Author(s) -
Biccard B. M.,
Sear J. W.,
Foëx P.
Publication year - 2005
Publication title -
anaesthesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.839
H-Index - 117
eISSN - 1365-2044
pISSN - 0003-2409
DOI - 10.1111/j.1365-2044.2005.04371.x
Subject(s) - medicine , atorvastatin , statin , perioperative , adverse effect , intensive care medicine , peri , surgery , emergency medicine
Summary We analysed the pharmaco‐economics of the prospective peri‐operative studies of statin administration for major elective vascular surgery, using the NHS reference costs for 2004. This analysis suggests that peri‐operative statin therapy for patients undergoing vascular surgery may present the most cost‐effective use of statin therapy yet described, with a number‐needed‐to‐treat of 15 and almost 60% of the total cost of atorvastatin therapy recovered through a reduction in peri‐operative adverse events.